Sitemap - 2025 - Transcripta Bio

AI for open-ended scientific explanations

Using LLMs to group pathways by function

Accelerating Drug Discovery with Transcriptomics: A Case Study

Transcripta Bio collaborates with Microsoft Research to Advance AI-Driven Disease-Gene Discovery

Transcripta Bio's new visual brand language

Mastering the transcriptome with artificial intelligence

Transcripta Bio Named to the TIME100 Most Influential Companies of 2024

Unveiling Transcripta Bio

Rarebase Names Chris Moxham as Chief Executive Officer

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts